Discovery of Taxus chinensis fruit wine as potentially functional food against Alzheimer's disease by UHPLC-QE-MS/MS, network pharmacology and molecular docking

被引:6
|
作者
Chen, Meimei [1 ,2 ]
Wang, Fengzhen [3 ]
Lei, Huangwei [1 ,2 ]
Li, Candong [1 ,2 ,4 ]
Yang, Zhaoyang [1 ,2 ,4 ]
机构
[1] Fujian Univ Tradit Chinese Med, Coll Tradit Chinese Med, Fuzhou, Peoples R China
[2] Fujian Univ Tradit Chinese Med, Fujian Key Lab TCM Hlth Status Identificat, Fuzhou, Peoples R China
[3] State Adm Tradit Chinese Med, Certificat Ctr Chinese Phys, Beijing, Peoples R China
[4] Fujian Univ Tradit Chinese Med, Coll Tradit Chinese Med, Fuzhou 350122, Fujian, Peoples R China
基金
中国国家自然科学基金;
关键词
Alzheimer's disease; molecular docking; network pharmacology; UHPLC-QE-MS; MS; BETULA-PLATYPHYLLA; PROTEIN; GENES; MODEL;
D O I
10.1111/jfbc.14502
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nowadays, there is no specific cure for Alzheimer's disease (AD), but the progression of AD can be improved by preventive interventions. The wine of Taxus chinensis fruit (TCFW) has the effect of improving human immunity and anti-aging as a long history of health care wine in folk, especially popular in the longevity villages in China, which may be potentially effective dietary products to improve AD. However, the chemical constituents and molecular mechanisms of TCFW still remain unknown. In this study, chemical profiling with UHPLC-QE-MS/MS, network pharmacology and molecular docking were integrated to fastly explore the potential chemicals and mechanisms of TCFW against AD. A total of 31 chemical components in TCFW were detected and identified compared with the solvent wine of TCFW by UHPLC-QE-MS/MS. Then, 27 potential key targets and 14 chemical compounds of TCFW were uncovered for the improvement of AD by network pharmacology and molecular docking. These 14 compounds were reported to have diverse bioactivities such as neuroprotective activity, antifibrotic activity, anticancer activity, antiviral activity and effectiveness in the treatment of neuronal injury, Alzheimer's disease, etc. Among these 27 targets affected by TCFW predicted by our approach, AKT1, PTGS2, NOS3, NOS2, INS, ESR1, ESR2, BDNF, IL6, IL1B, DRD2 and ACHE were significantly altered in AD. The GO and KEGG enrichment analyses revealed that TCFW mainly acted on oxidative response, inflammatory response, insulin secretion, amyloid fibril formation, neurodegenerative pathway-multiple diseases, Alzheimer's disease, longevity regulation pathway, PI3K-Akt signaling pathway, MAPK signaling pathway, etc, which were the main pathogenesis of AD. Practical applicationsAlzheimer's disease (AD) is a degenerative neurological disorder characterized by cognitive and behavioral dysfunction. Nowadays, there is no specific cure for AD, but the progression of AD can be improved by preventive interventions. The wine of Taxus chinensis fruit (TCFW) has the effect of improving human immunity and anti-aging as a long history of health care wine in folk, especially popular in the longevity villages in China, which may be potentially effective dietary products to improve AD. This study proposed a fastly integrated method to explore the potential chemicals and mechanisms of TCFW against AD by UHPLC-QE-MS/MS, network pharmacology and molecular docking. Here, we found that TCFW may ameliorate AD by reversing many biological events, including oxidative stress, inflammatory response, neuronal apoptosis, insulin secretion, amyloid fibril formation, and T cell co-stimulation, which may provide some insights for the development and research of anti-AD drugs.
引用
收藏
页数:12
相关论文
共 21 条
  • [1] Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques
    Zhang, Yibin
    Chang, Tianying
    Lu, Qi
    Cui, Yingzi
    Zhang, Dongmei
    Wang, Baitong
    Xu, Peng
    Lu, Jing
    Ma, Jinhui
    Lv, Zhiguo
    Wang, Jian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [2] Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques
    Zhang, Yibin
    Chang, Tianying
    Lu, Qi
    Cui, Yingzi
    Zhang, Dongmei
    Wang, Baitong
    Xu, Peng
    Lu, Jing
    Ma, Jinhui
    Lv, Zhiguo
    Wang, Jian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [3] Deciphering the multi-functional role of Indian propolis for the management of Alzheimer's disease by integrating LC-MS/MS, network pharmacology, molecular docking, and in-vitro studies
    Sankaran, Sandeep
    Dubey, Rahul
    Gomatam, Anish
    Chakor, Rishikesh
    Kshirsagar, Ashwini
    Lohidasan, Sathiyanarayanan
    MOLECULAR DIVERSITY, 2024, 28 (06) : 4325 - 4342
  • [4] Integrating network pharmacology, UPLC-Q-TOF-MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
    Shen, Zhuo Jun
    Fu, Yun Bo
    Hou, Jin Ling
    Lin, Lu Ning
    Wang, Xiao Yan
    Li, Chang Yu
    Yang, Yuan Xiao
    CHINESE MEDICINE, 2022, 17 (01)
  • [5] Integrating network pharmacology, UPLC-Q–TOF–MS and molecular docking to investigate the effect and mechanism of Chuanxiong Renshen decoction against Alzheimer's disease
    Zhuo Jun Shen
    Yun Bo Fu
    Jin Ling Hou
    Lu Ning Lin
    Xiao Yan Wang
    Chang Yu Li
    Yuan Xiao Yang
    Chinese Medicine, 17
  • [6] Insights into diosgenin against inflammatory bowel disease as functional food based on network pharmacology and molecular docking
    Cai, Min
    Mao, Yangchen
    Gao, Wenjing
    Wang, Zhenzhen
    Mao, Jianwei
    Sha, Ruyi
    HELIYON, 2024, 10 (18)
  • [7] Mechanism interpretation of Guhan Yangshengjing for protection against Alzheimer's disease by network pharmacology and molecular docking
    Cheung, Suet
    Zhong, Yuan
    Wu, Lei
    Jia, Xiaomeng
    He, Meng-Qi
    Ai, Yongjian
    Jiao, Qisen
    Liang, Qionglin
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 328
  • [8] Elucidating the Molecular Targets and Mechanisms of Chlorogenic Acid Against Alzheimer's Disease via Network Pharmacology and Molecular Docking
    Liu, Xinxin
    Wang, Yabo
    LETTERS IN DRUG DESIGN & DISCOVERY, 2023, 20 (09) : 1329 - 1342
  • [9] The network pharmacology study and molecular docking to investigate the potential mechanism of Acoritataninowii Rhizoma against Alzheimer's Disease
    Zhi-Kun Qiu
    Bai-Xian Zhou
    Jiali Pang
    Wei-qiang Zeng
    Han-biao Wu
    Fan Yang
    Metabolic Brain Disease, 2023, 38 : 1937 - 1962
  • [10] The network pharmacology study and molecular docking to investigate the potential mechanism of Acoritataninowii Rhizoma against Alzheimer's Disease
    Qiu, Zhi-Kun
    Zhou, Bai-Xian
    Pang, Jiali
    Zeng, Wei-qiang
    Wu, Han-biao
    Yang, Fan
    METABOLIC BRAIN DISEASE, 2023, 38 (06) : 1937 - 1962